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INTRODUCTION
In cellular electrophysiological studies intracellular calcium
concentration is often buffered under experimental conditions
because of the wide variety of Ca2+-dependent ion currents,
including Na+ (1, 2), Ca2+ (3, 4), K+ (5, 6), Cl– (7, 8), Na+-Ca2+
exchanger (9, 10) and nonspecific cation (11, 12) currents in the
heart. In voltage clamp experiments, using typically patch
pipettes with large pore diameters, buffering of [Ca2+]i is
relatively easy, since dialysis of the intracellular compartment
with the Ca2+ chelator BAPTA is readily performed by the pipette
solution. When action potentials are recorded under physiological
conditions with conventional sharp microelectrodes this approach
is not available due to the small tip diameter of the recording
electrode. In this case the cell-permeant acetoxy-methylester
form of a Ca2+ chelator can be applied to reduce [Ca2+]i. Such
experiments have been performed for decades and their results
were interpreted exclusively in terms of buffering [Ca2+]i (13-17)
- in spite of the fact that BAPTA-AM (and also EGTA-AM) has
been shown to interact with K+ channels expressed in HEK cells
(18). Since drug-channel interactions may be markedly different
in native and expressed ion channels (19), it was reasonable to
test the effect of BAPTA-AM on IKr, which current has the
greatest influence on ventricular repolarization in larger
mammals. For the same reason the effect of BAPTA-AM on
action potential morphology was also studied. Canine ventricular
cells were chosen in these experiments because the
electrophysiological properties of this preparation best resemble
those of human myocardium (20, 21).
Our results indicate that in mammalian ventricular
cardiomyocytes BAPTA-AM affects APD in two separate ways:
in addition to the consequences of [Ca2+]i buffering, and thus
modifying the activity of Ca2+-dependent ionic currents, BAPTA-
AM also directly inhibits IKr.
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Intracellular calcium concentration ([Ca2+]i) is often buffered by using the cell-permeant acetoxy-methylester form of the
Ca2+ chelator BAPTA (BAPTA-AM) under experimental conditions. This study was designed to investigate the time-
dependent actions of extracellularly applied BAPTA-AM on action potential duration (APD) in cardiac cells. Action
potentials were recorded from enzymatically isolated canine ventricular myocytes with conventional sharp microelectrodes.
The effect of BAPTA-AM on the rapid delayed rectifier K+ current (IKr) was studied using conventional voltage clamp and
action potential voltage clamp techniques. APD was lengthened by 5 µM BAPTA-AM - but not by BAPTA - and shortened
by the Ca2+ ionophore A23187 in a time-dependent manner. The APD-lengthening effect of BAPTA-AM was strongly
suppressed in the presence of nisoldipine, and enhanced in the presence of BAY K8644, suggesting that a shift in the [Ca2+]i-
dependent inactivation of L-type Ca2+ current may be an important underlying mechanism. However, in the presence of the
IKr-blocker dofetilide or E-4031 APD was shortened rather than lengthened by BAPTA-AM. Similarly, the APD-lengthening
effect of 100 nM dofetilide was halved by the pretreatment with BAPTA-AM. In line with these results, IKr was significantly
reduced by extracellularly applied BAPTA-AM under both conventional voltage clamp and action potential voltage clamp
conditions. This inhibition of IKr was partially reversible and was not related to the Ca2+ chelator effect BAPTA-AM. The
possible mechanisms involved in the APD-modifying effects of BAPTA-AM are discussed. It is concluded that BAPTA-AM
has to be applied carefully to control [Ca2+]i in whole cell systems because of its direct inhibitory action on IKr.
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ion, currents, ventricular myocytes
MATERIALS AND METHODS
Isolation of single canine ventricular myocytes
Adult mongrel dogs of either sex were anaesthetized with
intramuscular injections of 10 mg/kg ketamine hydrochloride
(Calypsol, Richter Gedeon, Hungary) + 1 mg/kg xylazine
hydrochloride (Sedaxylan, Eurovet Animal Health BV, The
Netherlands) according to protocols approved by the local
ethical committee (license No 18/2012/DEMAB) in line with the
ethical standards laid down in the Declaration of Helsinki in
1964 and its later amendments. The hearts were quickly removed
and placed in Tyrode solution containing (in mM) NaCl, 144;
KCl, 5.6; CaCl2, 2.5; MgCl2, 1.2; HEPES, 5; and dextrose, 11; at
pH = 7.4. Single myocytes were obtained by enzymatic
dispersion using the segment perfusion technique, as described
previously (22, 23). Briefly, a wedge-shaped section of the left
ventricular wall supplied by the left anterior descending
coronary artery was cannulated, dissected and perfused with
oxygenized Tyrode solution. After removal of blood the
perfusion was switched to a nominally Ca2+-free Joklik solution
(Minimum Essential Medium Eagle, Joklik Modification,
Sigma-Aldrich Co., St. Louis, MO, USA) for 5 min. This was
followed by 35 min perfusion with Joklik solution supplemented
with 1 mg/ml collagenase (Type II. Worthington, Chemical Co.)
and 0.2% bovine serum albumin (Fraction V., Sigma-Aldrich
Co.) containing 50 µM Ca2+. The full transmural section of the
middle portion of the left ventricular wall was cut into small
pieces and the cell suspension was washed with Joklik solution.
These tissue chunks, however, contained dominantly myocytes
of midmyocardial origin. After gradually restoring the normal
external Ca2+ concentration, the cells were stored in Minimum
Essential Medium Eagle (Sigma-Aldrich Co.) until use. Drugs
were obtained from Sigma-Aldrich Co.
Recording of action potentials
All electrophysiological measurements were performed at
37°C as previously described (23). Rod-shaped viable cells
showing clear striation were sedimented in a plexiglass
chamber of 1 ml volume allowing continuous superfusion (at a
rate of 2 ml/min) with Tyrode solution. Transmembrane
potentials were recorded using 3 M KCl filled sharp glass
microelectrodes having tip resistance between 20 and 40 MO.
These electrodes were connected to the input of Multiclamp
700A or 700B amplifiers (Molecular Devices, Sunnyvale, CA,
USA). The cells were paced through the recording electrode at
a steady frequency of 1 Hz using 1 – 2 ms wide rectangular
current pulses having amplitudes of 120% of the diastolic
threshold. Since the cytosol was not dialyzed, time-dependent
changes in action potential morphology were negligible for the
period of our experimental protocol not lasting longer than 40
min. Action potentials were digitized at 200 kHz using Digidata
1332A or 1440A digitizers (Molecular Devices) and stored for
later analysis. BAPTA-AM was dissolved in DMSO to yield
5 mM stock solutions, which was diluted into the bathing
solution immediately before use.
Conventional voltage clamp
The cells were superfused at 37°C with a modified Tyrode
solution supplemented with 1 µM nisoldipine and 1 µM HMR
1556 to prevent the contamination with L-type Ca2+ current (ICa)
and the slow delayed rectifier K+ current (IKs) respectively. The
modified Tyrode solution contained (in mM): NaCl, 121; KCl, 4;
CaCl2, 1.3; MgCl2, 1; HEPES, 10; NaHCO3, 25; and glucose, 10;
at pH = 7.35. The osmolarity of this solution was 298 – 303
mOsm. Suction pipettes, made of borosilicate glass, had tip
resistances of 2 – 3 MO after filling with pipette solution,
containing (in mM) K-aspartate 100, KCl 45, MgCl2 1, HEPES
5, BAPTA 10, K-ATP 3, at pH = 7.2. Membrane currents were
recorded with Multiclamp 700A or 700B amplifier (Molecular
Devices) using the whole cell configuration of the patch clamp
technique. After establishing high (1 – 10 GO) resistance seal by
gentle suction, the cell membrane beneath the tip of the electrode
was disrupted by further suction or by applying 1.5 V electrical
pulses for 1 ms. Outputs from the amplifier were digitized at 20
kHz under software control (pClamp 10.0, Molecular Devices).
The IKr was activated by 500 ms long depolarizing pulses
clamped to +40 mV, arising from the holding potential of –80
mV. This protocol was repeated at a frequency of 0.05 Hz. IKr
was assessed as tail current amplitudes recorded following
repolarization to –40 mV for 10 s. Currents were normalized to
cell capacitance, determined in each cell using
hyperpolarizations from +10 to –10 mV for 15 ms. Series
resistance was typically 4 – 8 MO before compensation (usually
50 – 80%). Experiments were discarded when the series
resistance was high or substantially increased during the
measurement.
Action potential voltage clamp
After establishment of whole-cell configuration, action
potentials were recorded in current clamp mode from the
myocytes superfused with a modified Tyrode solution described
in the ‘conventional voltage clamp’ section. In these experiments
no ion channel blocker was applied in the external solution in
order to develop normal action potentials. The pipette solution
contained (in mM): K-aspartate 130, KCl 30, MgATP 3, HEPES
10, Na2-phosphocreatine 3, EGTA 0.01, cAMP 0.002, KOH 10,
at pH = 7.3. As a consequence, the experimental conditions
applied in action potential voltage clamp experiments were close
to physiological (24, 25). The cells were continuously paced
through the recording electrode at steady stimulation frequency
of 1 Hz. A previously recorded ‘canonic’ canine midmyocardial
action potential was applied to the voltage clamped cells as
command voltage. Current traces were recorded continuously
under ‘reference’ conditions (in the absence or presence of
BAPTA-AM in the bathing medium) and after the application of
the specific IKr inhibitor E 4031. IKr was defined as an E 4031-
sensitive current obtained by subtracting the traces obtained in
the presence of E 4031 from the ‘reference’ traces. To diminish
the consequences of trace-to-trace fluctuations and to reduce
noise, 20 consecutive IKr traces were averaged, and the averaged
curve was used for further analysis.
In these experiments, to rule out the changes in current traces
caused by the continuous calcium chelating effect of BAPTA-
AM, cells were pre-loaded with BAPTA-AM before the
measurements. To achieve this, cells were incubated with 5 µM
BAPTA-AM for 20 min, then washed twice with Tyrode solution,
and stored for at least further 15 minutes in BAPTA-AM-free
Tyrode. These BAPTA-AM loaded cells, which did not contract
when stimulated through the pipette, were used as control. To test
the acute effect of BAPTA-AM on IKr in another group of cells,
the superfusate was supplemented with 5 µM BAPTA-AM. In
both cases IKr was identified as E 4031-sensitive current.
Statistical analysis
Results are expressed as mean ± SEM values. Statistical
significance of differences from control was evaluated using
one-way ANOVA followed by Student’s t-test for paired or
unpaired data as pertinent. Differences were considered
significant when P was less than 0.05.
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RESULTS
Effect of BAPTA-AM on action potential morphology
The most conventional way to study the effect of changes in
[Ca2+]i on action potential configuration is loading the cell interior
with the Ca2+ chelator BAPTA using its cell-permeant acetoxy-
methylester form, or alternatively, to load the cells with Ca2+ using
the Ca2+-ionophore A23187. As presented in Fig. 1, exposure to 5
µM BAPTA-AM lengthened, while to A23187 shortened the
duration of action potentials measured at 90% level of
repolarization (APD90). These changes developed gradually in a
time-dependent manner (Fig. 1C) although in the case of BAPTA-
AM there was an initial rapid rise in APD90. Actions of BAPTA-
AM and A23187 failed to fully saturate within the recording
period of 30 min, probably due to the progressive intracellular
accumulation of free BAPTA resulting in a more and more
effective buffering of [Ca2+]i in the first case and accumulation of
Ca2+ in the second one. Furthermore, the changes in APD90 were
accompanied with characteristic changes in action potential
morphology, since reduction of [Ca2+]i shifted the plateau potential
to more positive voltages, while its elevation resulted in a marked
depression of the plateau (Fig. 1A and 1B).
The effect of BAPTA-AM was studied under conditions
when the density of ICa was manipulated. In the presence of the
Ca2+-channel blocker nisoldipine (26) the BAPTA-AM-induced
APD-lengthening was negligible (although statistically
significant) and only transient since it disappeared after 20 min
exposure to BAPTA-AM (Fig. 2B and 2D). In contrast,
increasing ICa-density with BAY K8644 (27) markedly
augmented the BAPTA-AM-induced prolongation of APD90
(Fig. 2C and 2D). It is worthy of note that BAPTA-AM showed
a biphasic effect in the presence of BAY K8644. After 5 min
exposure to BAPTA-AM APD90 reached its maximum, and after
this it shortened gradually reaching a local minimum around 15
min of BAPTA-AM treatment (Fig. 2C).
The effects of nisoldipine and BAY K8644 on action potential
configuration (plateau-depression by nisoldipine and elevation by
BAY K8644) were qualitatively similar to those seen with A23189
and BAPTA-AM, respectively. Taken these findings,
demonstrated in Fig. 1 and Fig. 2, together, one might logically
conclude that the reduction of [Ca2+]i lengthens while its elevation
shortens the action potential, furthermore, these effects are likely
mediated via the Ca2+-dependent inactivation of ICa (22).
Contrasting to the argumentation above, when the cells were
pretreated with IKr blocker (100 nM dofetilide or 300 nM E 4031)
BAPTA-AM shortened APD90 instead of lengthening it, as it is
demonstrated in Fig. 3C-3E. The applied concentrations of IKr
blockers eliminated more than 75% of IKr (28). This shortening
effect, however, was temporary - strongly resembling the transient
APD90-shortening tendency observed with BAPTA-AM in the
presence of BAY K8644 following the immediate APD90
lengthening effect of the former. On the other hand, the APD90-
lengthening effect of 100 nM dofetilide was significantly reduced
in the presence of 5 µM BAPTA-AM (Fig. 3F). The effect of
BAPTA-AM on action potential morphology was sensitive
exclusively to the density of IKr, since blocking IKs with 1 µM
HMR 1556 (29) failed to alter the effect of BAPTA-AM on action
potential duration (Fig. 3B and 3E). The effects of 5 min
pretreatment with nisoldipine, BAY K8644, dofetilide and E 4031
(drugs used before the exposure to BAPTA-AM in Fig. 2 and Fig.
3) on APD90 were comparable in magnitude to the those observed
after longer exposures, lasting for 20 - 30 min, as shown in Fig. 4.
This is important because any change in APD90 recorded in the
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Fig. 1. Effects of changes in [Ca2+]i on action potential duration (APD90). (A), (B): Pairs of representative action potentials recorded
from myocytes exposed to 5 µM BAPTA-AM (A) and 1 µM A23187 for 30 min (B). Time-dependent changes in APD90 are presented
in panel (C). Symbols and bars are means ± SEM, asterisks indicate significant changes from the pre-drug control values. Numbers in
parentheses indicate the number of myocytes studied.
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presence of BAPTA-AM cannot be attributed to time-dependent
progression of the effect of the drug used for pretreatment.
To demonstrate that not BAPTA - but only BAPTA-AM - is
responsible for the observed alterations in action potential
morphology, myocytes were superfused with 5 µM BAPTA. No
change in action potential duration or in other parameters were
observed after 30 min exposure to BAPTA. (Fig. 5A and 5B)
indicating that the presence of the acetoxy-methyl group in the
molecule is essential for the development of acute APD-
lengthening effect of BAPTA-AM. The stability of our action
potentials are documented in Fig. 5C and 5D. Both the duration
as well as the configuration of action potentials failed to alter
significantly in untreated canine ventricular cells within the 60
min period of recording.
Effect of BAPTA-AM on IKr current
In the first set of experiments, the effect of externally applied
BAPTA-AM was studied on IKr in 5 ventricular myocytes using
the conventional patch clamp technique. The density of IKr was
evaluated by the amplitude of IKr tail currents recorded upon
repolarization to –40 mV. As indicated by Fig. 6, exposure of the
cells to 5 µM BAPTA-AM for 5 min decreased the density of IKr
to 32 ± 8 % of the control (from 0.39 ± 0.05 to 0.12 ± 0.03 A/F,
P < 0.05, n = 5) in a partially reversible manner, since the current
amplitude returned to 76 ± 5% of its control value during a 5 min
period of washout with BAPTA-AM-free superfusate. As the
pipette solution contained 10 mM BAPTA in these experiments,
suppression of IKr by BAPTA-AM was independent of
intracellular Ca2+ buffering.
Conventional voltage clamp experiments are not ideal to
visualize the consequences of an ion current blockade during the
action potential. Therefore action potential voltage clamp
experiments have been designed to monitor the changes in IKr
current profile following superfusion with 5 µM BAPTA-AM
(Fig. 7). Since this technique is based on pharmacological
extraction of IKr (using 1 µM E 4031), measurements had to be
performed in two populations of myocytes. The density of IKr
measured in the absence (control) and presence of external
BAPTA-AM was 0.50 ± 0.03 and 0.17 ± 0.06 A/F (n = 7 and n
= 5, respectively, P < 0.05), corresponding to a reduction of 66%.
There was a similar difference in the amount of charge carried
by IKr during the action potential: 22 ± 5 versus 6 ± 2 mC/F (n =
7 and n = 5, respectively, P < 0.05), a reduction to 27% of the
control value. The Ca2+-buffering effect of BAPTA-AM could be
excluded in these experiments as well, because the cells had
been pre-loaded with BAPTA before their exposure to external
BAPTA-AM (see the Methods section for details).
DISCUSSION
In the present study, we have clearly shown that the
frequently used Ca2+ chelator BAPTA-AM effectively and
reversibly blocked IKr in canine ventricular myocytes. Our
results are in an excellent agreement with the results of Tang
et al. (18), who reported an IC50 value of 1.3 µM for BAPTA-
AM on hERG channels (and similar values for other K+
channels) expressed in HEK 293 cells. These authors also
reported an open channel block with BAPTA-AM. Therefore
it is somewhat surprising that a similar degree of block was
observed under conventional and action potential voltage
clamp conditions (reduction to 32 and 34% of the control
values, respectively). Probably the consequences of the more
positive activation voltage of +40 mV, applied in conventional
voltage clamp, compared to the less positive action potential
plateau in action potential voltage clamp experiments, was
offset by the higher stimulation frequency of 1 Hz used in the
latter experimental design. The most important message of
both voltage clamp experiments is that external BAPTA-AM
must not be used as an experimental Ca2+ chelator when
studying the Ca2+ dependence of cardiac ion currents in whole
cell systems expressing hERG channels, because of the direct
inhibitory effect of BAPTA-AM on IKr current.
Based on the present results, the exposure to BAPTA-AM
displays a very complex pattern of changes in APD90, so
explanation of the results is necessarily speculative. The rapidly
developing acute effect of BAPTA-AM, the significant
prolongation of APD90, is very likely due to the BAPTA-AM-
induced inhibition of IKr, an effect evident within the initial 5 min
of exposure. This explanation apparently contradicts to the finding
that the acute lengthening effect of BAPTA-AM was reduced by
nisoldipine and augmented by BAY K8644, which might suggest
some kind of involvement of ICa in the concomitant changes of
APD90. However, not only ICa was increased or suppressed by
BAY K8644 and nisoldopine, respectively, but also the pre-
BAPTA value of APD90 as well as the level of the plateau
potential. Consequences of the IKr-blockade strongly increases
when APD90 is longer (30, 31), as was the case in the presence of
BAY K8644, and decreases if APD90 is shorter, as was observed in
the presence of nisoldipine. In addition, the relative importance of
IKr in regulation of APD90 strongly increases with positive shifts in
the plateau potential due to the faster activation of IKr at more
positive voltages (28). This may also contribute to the stronger
BAPTA-AM-induced prolongation in the presence of BAY K8644
versus the smaller change observed in nisoldipine.
When the IKr-blocking effect of BAPTA-AM was prevented
by pretreatment of the cells with IKr blocking drugs, like
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Fig. 3. Time-dependent effects of BAPTA-AM on action potential duration in the presence of different delayed rectifier potassium
current blockers. (A): Effects of 5 min exposure to 1 µM HMR 1556, 100 nM dofetilide and 300 nM E 4031 on action potential
configuration (black records). Action potentials taken following 30 min BAPTA-AM superfusion (in the continuous presence of HMR
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the IKr blocker dofetilide (C) or E-4031 (D). Open symbols represent data measured before the exposure to BAPTA-AM (first symbol:
control; second symbol: 5 min pretreatment with HMR 1556, dofetilide or E 4031), filled symbols show data after superfusion with
BAPTA-AM in the presence of HMR 1556, dofetilide or E 4031. (E): Changes in APD90 values observed at 5 and 30 min of BAPTA-
AM treatment after pretreatment with various K+ channel blockers. (F): APD-lengthening effect of 100 nM dofetilide alone and in the
presence of 5 µM BAPTA-AM. Symbols, columns and bars are arithmetic means ± SEM, asterisks denote significant differences from
pre-BAPTA-AM (control) values, while crosses refer to significant changes comparing to the ‘BAPTA-AM alone’ group. Numbers in
parentheses indicate the number of myocytes studied. In panel (F), the asterisk denotes significant difference obtained in the absence
and presence of BAPTA-AM.
dofetilide or E 4031, BAPTA-AM initially shortened APD90, an
effect likely related to the reduction of [Ca2+]i. The most
plausible explanation for this BAPTA-AM-induced shortening is
the conversion of the normally inwardly directed Na+/Ca2+
exchange (NCX) current to an outwardly directed one as a
consequence of the reduced [Ca2+]i. In line with this, the
tendency of APD-shortening observed after the initial BAPTA-
AM-induced prolongation in myocytes pretreated with BAY
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represent mean ± SEM
values, numbers in
parentheses indicate the
number of myocytes
studied.
K8644 was also pronounced probably because the long APD90
and the positive plateau potential favored the reverse mode
activity of NCX (32, 33). This effect is in line with the finding
that buffering [Ca2+]i significantly shortened APD90 in rat, guinea
pig and ferret cardiomyocytes (34, 35) and with own
unpublished results, obtained in guinea pig ventricular cells,
indicating that net NCX current was outward when recorded
with EGTA-containing patch pipettes.
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Fig. 6. Effect of BAPTA-AM on IKr under conventional voltage clamp conditions. (A): Representative set of superimposed IKr tail
current traces recorded following repolarization to –40 mV. The current was activated at +40 mV for 500 ms as shown by the applied
voltage protocol (above). The cell was exposed to 5 µM BAPTA-AM for 5 min, which was followed by a subsequent 5 min period of
washout. (B): Average IKr tail current amplitudes measured before (control) in the presence of, and after the washout of BAPTA-AM.
Columns and bars are arithmetic means ± SEM, asterisks denote significant differences from control, the cross refers to significant
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As documented in Figs. 3C and 3D, the BAPTA-AM-
induced APD90-shortening effect was transient. In other words,
there was a progressive tendency of prolongation during a long-
lasting exposure to BAPTA-AM. This was also evident under
control conditions, where no transient shortening was observed
(only a small notch after 5 min). The final lengthening tendency
of APD90 is likely related to the combination of two further
effects of progressive buffering of [Ca2+]i. These are the
augmentation of the ICa due to the reduction of its Ca2+-
dependent inactivation (22) and offsetting some Ca2+-dependent
outward currents, like the Ca2+-dependent Cl- current by
buffering [Ca2+]i (7, 8). In summary, buffering of [Ca2+]i resulted
in a biphasic response of APD90: a transient initial shortening
was followed by progressive prolongation when the IKr-blocking
effect of BAPTA-AM was prevented by the pretreatment with
dofetilide or E 4031.
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